Narrator: This is Science Today. People living with HIV can now expect to live longer, healthier lives, thanks to new drug treatments. But with longer lives comes a whole array of other health problems - those suffered by all aging people. Doctor Michelle Roland is directing a new study at the University of California, San Francisco to see how people with HIV react to organ transplants.
Roland: The concern is if you take a person who has a disease that's characterized by immuno-suppression, and then you have to give them immuno-suppressing drugs after the transplant so their body doesn't reject this organ that they see as foreign, that you might make the disease progress much more quickly and make them do worse.
Narrator: So far in a small local study, the transplant success rate seems very good. Now Roland hopes to answer some lingering questions with the larger study.
Roland: The safety question is do the immuno-suppressant drugs required for transplant make HIV worse, and the effectiveness question is, does HIV make the transplant not work as well.
Narrator: For Science Today, I'm Larissa Branin.